Showing results (201-210 of 275) with videos related to
Sort By:
Pageof 28
Journal of Medical Virology|November 26, 2008
Cytokine responses in a severe case of glandular fever treated successfully with foscarnet combined with prednisolone and intravenous immunoglobulinChristine Ma, Chun K Wong, Bonnie C K Wong, et al.The Journal of Infectious Diseases|July 17, 2019
Treatment-Emergent Influenza Variant Viruses With Reduced Baloxavir Susceptibility: Impact on Clinical and Virologic Outcomes in Uncomplicated InfluenzaTakeki Uehara, Frederick G Hayden, Keiko Kawaguchi, et al.The Journal of Infectious Diseases|October 5, 2023
Effectiveness of mRNA COVID-19 Monovalent and Bivalent Vaccine Booster Doses Against Omicron Severe Outcomes Among Adults Aged ≥50 Years in Ontario, Canada: A Canadian Immunization Research Network StudyRamandip Grewal, Sarah A Buchan, Lena Nguyen, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 17, 2012
H5N1 avian influenza in childrenAhmet Faik Oner, Nazim Dogan, Viktor Gasimov, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 24, 2023
Protection Conferred by COVID-19 Vaccination, Prior SARS-CoV-2 Infection, or Hybrid Immunity Against Omicron-Associated Severe Outcomes Among Community-Dwelling AdultsNelson Lee, Lena Nguyen, Peter C Austin, et al.Nature Communications|December 3, 2015
Rapid emergence and predominance of a broadly recognizing and fast-evolving norovirus GII.17 variant in late 2014Martin C W Chan, Nelson Lee, Tin-Nok Hung, et al.Nature Communications|October 21, 2022
Priming conditions shape breadth of neutralizing antibody responses to sarbecovirusesJanice Zhirong Jia, Chee Wah Tan, Samuel M S Cheng, et al.Nature Communications|November 10, 2025
Greater benefits of immediate nirmatrelvir-ritonavir initiation for post-COVID outcomes: a population-based retrospective cohort studyKa Chun Chong, Yuchen Wei, Carlos King Ho Wong, et al.The Journal of Infection|May 28, 2023
Effectiveness of mRNA and inactivated COVID-19 vaccines: A test-negative study in an infection-naïve Hong Kong populationRita W Y Ng, Ryan K H Sze, Ka Chun Chong, et al.Nature Communications|January 5, 2021
Neutralizing antibody titres in SARS-CoV-2 infectionsEric H Y Lau, Owen T Y Tsang, David S C Hui, et al.Pageof 28